Ifp Advisors, Inc Alkermes Plc. Transaction History

Ifp Advisors, Inc

$3.07 Billion
Q1 2025

A detailed history of Ifp Advisors, Inc transactions in Alkermes Plc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 82 shares of ALKS stock, worth $2,385. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 82 -0.0%

Holding current value

$2,385

Previous $2,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	BUY	$25.7 - $31.46 $1,105 - $1,352	43 Added 110.26%	82 $2,000
Q1 2024 Jul 30, 2024	BUY	$26.4 - $32.56 $1,029 - $1,269	39 New	39 $1,000
Q3 2022 Nov 08, 2022	BUY	$22.0 - $31.87 $264 - $382	12 New	12 $1,000
Q3 2021 Oct 06, 2021	SELL	$23.37 - $32.13 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$18.78 - $25.15 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$18.21 - $23.2 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	BUY	$15.39 - $22.1 $0 - $0	0 New	0 $0
Q3 2020 Oct 29, 2020	BUY	$16.16 - $20.66 $0 - $0	0 New	0 $0
Q2 2020 Aug 05, 2020	SELL	$13.31 - $19.41 $2,608 - $3,804	-196 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$13.06 - $21.24 $731 - $1,189	56 Added 40.0%	196 $4,000
Q4 2019 Jan 17, 2020	SELL	$17.29 - $21.74 $5,532 - $6,956	-320 Reduced 69.57%	140 $3,000
Q3 2019 Nov 07, 2019	BUY	$19.51 - $24.28 $3,726 - $4,637	191 Added 71.0%	460 $9,000
Q1 2019 May 15, 2019	SELL	$28.4 - $36.49 $7,071 - $9,086	-249 Reduced 48.07%	269 $10,000
Q4 2018 Jan 23, 2019	SELL	$27.94 - $44.61 $7,264 - $11,598	-260 Reduced 33.42%	518 $15,000
Q3 2018 Oct 25, 2018	SELL	$38.6 - $46.12 $8,607 - $10,284	-223 Reduced 22.28%	778 $0
Q2 2018 Aug 07, 2018	SELL	$40.56 - $51.36 $58,365 - $73,907	-1,439 Reduced 58.98%	1,001 $0
Q1 2018 Jun 03, 2019	BUY	$53.61 - $67.26 $7,612 - $9,550	142 Added 6.18%	2,440 $134,000
Q1 2018 May 09, 2018	SELL	$53.61 - $67.26 $7,612 - $9,550	-142 Reduced 5.82%	2,298 $0
Q4 2017 Jan 24, 2018	SELL	$47.69 - $55.39 $9,442 - $10,967	-198 Reduced 7.51%	2,440 $0
Q3 2017 Oct 30, 2017	SELL	$49.16 - $54.45 $70,593 - $78,190	-1,436 Reduced 35.25%	2,638 $134,000
Q2 2017 Jun 03, 2019	BUY	N/A	1,002 Added 32.62%	4,074 $236,000
Q1 2017 Jun 03, 2019	BUY	N/A	260 Added 9.25%	3,072 $180,000
Q4 2016 Jun 03, 2019	BUY	N/A	906 Added 47.53%	2,812 $156,000
Q2 2016 Jun 03, 2019	BUY	N/A	1,637 Added 608.55%	1,906 $82,000
Q1 2016 Jun 03, 2019	BUY	N/A	269	269 $10,000

Others Institutions Holding ALKS

# of Institutions

410

Shares Held

177M

Call Options Held

229K

Put Options Held

436K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.78B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account